FI54704C - ANALOGIFICATION OF THERAPEUTIC ACTIVATION OF ACTIVE L-ALPHA-HYDRAZINE-ALPHA-METHYL-BETA- (3,4-DIHYDROXIPHENYL) -PROPIONYRA - Google Patents

ANALOGIFICATION OF THERAPEUTIC ACTIVATION OF ACTIVE L-ALPHA-HYDRAZINE-ALPHA-METHYL-BETA- (3,4-DIHYDROXIPHENYL) -PROPIONYRA

Info

Publication number
FI54704C
FI54704C FI171370A FI171370A FI54704C FI 54704 C FI54704 C FI 54704C FI 171370 A FI171370 A FI 171370A FI 171370 A FI171370 A FI 171370A FI 54704 C FI54704 C FI 54704C
Authority
FI
Finland
Prior art keywords
alpha
propionyra
dihydroxiphenyl
analogification
hydrazine
Prior art date
Application number
FI171370A
Other languages
Finnish (fi)
Other versions
FI54704B (en
Inventor
Sandor Karady
Manuel Guing Ly
John Edward Allegretti
Seemon Hayden Pines
Meyer Sletzinger
Jr Arthur Stephen Wildman
Original Assignee
Merck & Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from CA078,419,A external-priority patent/CA951661A/en
Priority claimed from CA078,423A external-priority patent/CA971974A/en
Priority claimed from CA078,421,A external-priority patent/CA951662A/en
Priority claimed from CA078,417A external-priority patent/CA956969A/en
Priority claimed from CA078420A external-priority patent/CA929483A/en
Priority claimed from CA078424A external-priority patent/CA919691A/en
Application filed by Merck & Co Inc filed Critical Merck & Co Inc
Publication of FI54704B publication Critical patent/FI54704B/en
Application granted granted Critical
Publication of FI54704C publication Critical patent/FI54704C/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D263/00Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/08Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D263/16Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D263/18Oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C243/00Compounds containing chains of nitrogen atoms singly-bound to each other, e.g. hydrazines, triazanes
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C243/00Compounds containing chains of nitrogen atoms singly-bound to each other, e.g. hydrazines, triazanes
    • C07C243/24Hydrazines having nitrogen atoms of hydrazine groups acylated by carboxylic acids
    • C07C243/38Hydrazines having nitrogen atoms of hydrazine groups acylated by carboxylic acids with acylating carboxyl groups bound to carbon atoms of six-membered aromatic rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C51/00Preparation of carboxylic acids or their salts, halides or anhydrides
    • C07C51/347Preparation of carboxylic acids or their salts, halides or anhydrides by reactions not involving formation of carboxyl groups
    • C07C51/363Preparation of carboxylic acids or their salts, halides or anhydrides by reactions not involving formation of carboxyl groups by introduction of halogen; by substitution of halogen atoms by other halogen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D229/00Heterocyclic compounds containing rings of less than five members having two nitrogen atoms as the only ring hetero atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/04Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D233/28Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/30Oxygen or sulfur atoms
    • C07D233/32One oxygen atom
    • C07D233/38One oxygen atom with acyl radicals or hetero atoms directly attached to ring nitrogen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D241/00Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
    • C07D241/02Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings
    • C07D241/06Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having one or two double bonds between ring members or between ring members and non-ring members
    • C07D241/08Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having one or two double bonds between ring members or between ring members and non-ring members with oxygen atoms directly attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D273/00Heterocyclic compounds containing rings having nitrogen and oxygen atoms as the only ring hetero atoms, not provided for by groups C07D261/00 - C07D271/00
    • C07D273/02Heterocyclic compounds containing rings having nitrogen and oxygen atoms as the only ring hetero atoms, not provided for by groups C07D261/00 - C07D271/00 having two nitrogen atoms and only one oxygen atom
    • C07D273/04Six-membered rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
FI171370A 1969-06-18 1970-06-17 ANALOGIFICATION OF THERAPEUTIC ACTIVATION OF ACTIVE L-ALPHA-HYDRAZINE-ALPHA-METHYL-BETA- (3,4-DIHYDROXIPHENYL) -PROPIONYRA FI54704C (en)

Applications Claiming Priority (14)

Application Number Priority Date Filing Date Title
US83530769A 1969-06-18 1969-06-18
US88637169A 1969-12-18 1969-12-18
US905270A 1970-02-05 1970-02-05
US1377070A 1970-02-24 1970-02-24
US2207670A 1970-03-23 1970-03-23
CA78422 1970-03-25
CA078,419,A CA951661A (en) 1970-03-25 1970-03-25 Process for preparing substituted phenylalkanoic acids
CA078,423A CA971974A (en) 1970-03-25 1970-03-25 Intermediates for preparing phenylalkanoic acids
CA78418 1970-03-25
CA078,421,A CA951662A (en) 1970-03-25 1970-03-25 Process for preparing substituted phenylalkanoic acids
CA78425 1970-03-25
CA078,417A CA956969A (en) 1970-03-25 1970-03-25 Process for preparing substituted phenylalkanoic acids and intermediates
CA078420A CA929483A (en) 1970-03-25 1970-03-25 Process for preparing substituted phenylalkanoic acids
CA078424A CA919691A (en) 1970-03-25 1970-03-25 Process for preparing substituted phenylalkanoic acids and intermediates

Publications (2)

Publication Number Publication Date
FI54704B FI54704B (en) 1978-10-31
FI54704C true FI54704C (en) 1979-02-12

Family

ID=27584632

Family Applications (1)

Application Number Title Priority Date Filing Date
FI171370A FI54704C (en) 1969-06-18 1970-06-17 ANALOGIFICATION OF THERAPEUTIC ACTIVATION OF ACTIVE L-ALPHA-HYDRAZINE-ALPHA-METHYL-BETA- (3,4-DIHYDROXIPHENYL) -PROPIONYRA

Country Status (3)

Country Link
DK (1) DK138448C (en)
FI (1) FI54704C (en)
NL (1) NL7008881A (en)

Also Published As

Publication number Publication date
DK138448B (en) 1978-09-11
NL7008881A (en) 1970-12-22
FI54704B (en) 1978-10-31
DK138448C (en) 1979-02-19

Similar Documents

Publication Publication Date Title
NO138807C (en) ANALOGICAL PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE E 3-MARKAPTOTIADIAZOLE OR MARKAPTOTETRAZOLE-CEPHALOSPORINE
FI55333B (en) REFERENCE FORM OF FRAMSTAELLNING AV N- (1,1,1-TRISUBSTITUERADE) -METHYLAZOLER
SE7803115L (en) PACEMAKER
AT302522B (en) Pacemaker
SE7501655L (en) TISSUE TREATMENT.
FI53659C (en) DEPAODRAGEER AV VILKA DET ACTIVE AEMNET FRIGOERS EXPONENTIELLT
FI54314B (en) FORMULATION OF PYRIMIDIN-OCH 6-AZAPYRIMIDINNUCLEOSIDER
SE399427B (en) PROCEDURE FOR THE PREPARATION OF 2,4 DIAMINO-BENZYLPYRIMIDINES
FI53429C (en) FOERSEGLAD KUVERTLIKNANDE FOERPACKNING FOERETRAEDESVIS FOER STERIL INPACKNING AV SURGICAL REDSKAP
FI55507B (en) FREQUENCY REQUIREMENT FOR THERAPEUTIC ACTIVATION 1 2 5-THIADIAZOLE
BR7200199D0 (en) ACTIVE AGENT OSMOTIC DISTRIBUTOR
BR6915239D0 (en) THERAPEUTIC AGENTS
FI53700C (en) FRAMEWORK FOR THE ADMINISTRATION OF THERAPEUTIC THERAPEUTIC DIAMINOPROPIOFENONDERIVAT
AT293293B (en) Deodorizer
SE396599B (en) PROCEDURE FOR PREPARATION OF 1,2-DI-SUBSTITUTED HYDRAZINS
FI54704B (en) ANALOGIFICATION OF THERAPEUTIC ACTIVATION OF ACTIVE L-ALPHA-HYDRAZINE-ALPHA-METHYL-BETA- (3,4-DIHYDROXIPHENYL) -PROPIONYRA
BG17694A3 (en) INSECTICIDE
BE755833A (en) ROTARY BADERNS OF ETRAVE
BR6915086D0 (en) THERAPEUTIC AGENTS
FI56838B (en) ANALOGIFICATION OF THERAPEUTIC ACTIVATION OF THERAPEUTIC ACTIVE 6-DESOXY-6-AZIDO-7,8-DIHYDROISOMORFINDER
SE398878B (en) PROCEDURE FOR THE PREPARATION OF SUBSTITUTED 2,4-DIAMINO-5-BENZYLPYRIMIDINES
BG17463A3 (en) INSECTICIDE
FI46570B (en) FOERFARANDE FOER ATT SAEKERSTAELLA IDENTIFIERING I EN LABORATORIEUNDERSOEKNING AV EN PATIENT
BE760692A (en) THERAPEUTIC COMPOSITIONS
BR6915246D0 (en) THERAPEUTIC AGENTS